These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 16443183

  • 21. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [Abstract] [Full Text] [Related]

  • 22. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P, Hsu HY, Chiou SS, Chao MC.
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [Abstract] [Full Text] [Related]

  • 23. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.
    Lawson KA, Johnsrud M, Hodgkins P, Sasané R, Crismon ML.
    Clin Ther; 2012 Apr; 34(4):944-956.e4. PubMed ID: 22444786
    [Abstract] [Full Text] [Related]

  • 24. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

  • 25. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.
    Jackson J, Fernandes AW, Nelson W.
    Clin Ther; 2006 Sep; 28(9):1462-71. PubMed ID: 17062318
    [Abstract] [Full Text] [Related]

  • 26. Injury among stimulant-treated youth with ADHD.
    Marcus SC, Wan GJ, Zhang HF, Olfson M.
    J Atten Disord; 2008 Jul; 12(1):64-9. PubMed ID: 17934179
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pediatric emergency department overcrowding: electronic medical record for identification of frequent, lower acuity visitors. Can we effectively identify patients for enhanced resource utilization?
    Simon HK, Hirsh DA, Rogers AJ, Massey R, Deguzman MA.
    J Emerg Med; 2009 Apr; 36(3):311-6. PubMed ID: 18657929
    [Abstract] [Full Text] [Related]

  • 29. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH.
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [Abstract] [Full Text] [Related]

  • 30. ADHD and the rise in stimulant use among children.
    Mayes R, Bagwell C, Erkulwater J.
    Harv Rev Psychiatry; 2008 Jan; 16(3):151-66. PubMed ID: 18569037
    [Abstract] [Full Text] [Related]

  • 31. Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
    Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson TM, Xie J, Erder MH, Dammerman RS, Robertson B, Wu EQ.
    Am J Manag Care; 2014 Sep; 20(9):711-21. PubMed ID: 25365746
    [Abstract] [Full Text] [Related]

  • 32. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ, Mautone JA, Manz PH, Frye L, Blum NJ.
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [Abstract] [Full Text] [Related]

  • 33. Annual report on health care for children and youth in the United States: focus on injury-related emergency department utilization and expenditures.
    Owens PL, Zodet MW, Berdahl T, Dougherty D, McCormick MC, Simpson LA.
    Ambul Pediatr; 2008 Jan; 8(4):219-240.e17. PubMed ID: 18644545
    [Abstract] [Full Text] [Related]

  • 34. Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity.
    Ray GT, Levine P, Croen LA, Bokhari FA, Hu TW, Habel LA.
    Arch Pediatr Adolesc Med; 2006 Oct; 160(10):1063-9. PubMed ID: 17018466
    [Abstract] [Full Text] [Related]

  • 35. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.
    Poulton A.
    Expert Rev Neurother; 2006 Apr; 6(4):551-61. PubMed ID: 16623654
    [Abstract] [Full Text] [Related]

  • 36. Association between treatment with central nervous system stimulants and Raynaud's syndrome in children: a retrospective case-control study of rheumatology patients.
    Goldman W, Seltzer R, Reuman P.
    Arthritis Rheum; 2008 Feb; 58(2):563-6. PubMed ID: 18240233
    [Abstract] [Full Text] [Related]

  • 37. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 38. Volumetric MRI differences in treatment-naïve vs chronically treated children with ADHD.
    Semrud-Clikeman M, Pliśzka SR, Lancaster J, Liotti M.
    Neurology; 2006 Sep 26; 67(6):1023-7. PubMed ID: 17000972
    [Abstract] [Full Text] [Related]

  • 39. Reducing the number of emergency department visits and costs associated with anxiety: a randomized controlled study.
    Kolbasovsky A, Reich L, Futterman R, Meyerkopf N.
    Am J Manag Care; 2007 Feb 26; 13(2):95-102. PubMed ID: 17286529
    [Abstract] [Full Text] [Related]

  • 40. Stimulant medication use and response to growth hormone therapy: an NCGS database analysis.
    Frindik JP, Morales A, Fowlkes J, Kemp S, Thrailkill K, Lippe B, Dana K.
    Horm Res; 2009 Feb 26; 72(3):160-6. PubMed ID: 19729947
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.